Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1995 4
1996 3
1997 1
1998 2
1999 3
2002 2
2003 5
2004 1
2005 3
2006 2
2007 3
2008 1
2009 3
2010 6
2011 4
2012 6
2013 1
2014 4
2015 1
2016 2
2017 5
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 28676587

64 results
Results by year
Filters applied: . Clear all
Page 1
Drug pricing reforms promising but problematic.
Vogel L. Vogel L. CMAJ. 2017 Jul 4;189(26):E899-E900. doi: 10.1503/cmaj.1095436. CMAJ. 2017. PMID: 28676587 Free PMC article. No abstract available.
Ethical issues in drug pricing.
Holechek MJ. Holechek MJ. ANNA J. 1993 Oct;20(5):601-3. ANNA J. 1993. PMID: 8285804 No abstract available.
Pharmaceutical supply chain in China: current issues and implications for health system reform.
Yu X, Li C, Shi Y, Yu M. Yu X, et al. Health Policy. 2010 Sep;97(1):8-15. doi: 10.1016/j.healthpol.2010.02.010. Epub 2010 Mar 21. Health Policy. 2010. PMID: 20307912 Review.
Controversy in public hospital reforms in China.
Guan X, Qi L, Liu L. Guan X, et al. Lancet Glob Health. 2016 Apr;4(4):e240. doi: 10.1016/S2214-109X(16)00041-3. Lancet Glob Health. 2016. PMID: 27013311 Free article. No abstract available.
Pharmaceutical pricing. Health care purchasing at risk.
Betz R. Betz R. Health Syst Rev. 1995 Jan-Feb;28(1):21-3. Health Syst Rev. 1995. PMID: 10139753 No abstract available.
Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?
Gencarelli DM. Gencarelli DM. NHPF Issue Brief. 2002 Jun 7;(775):1-19. NHPF Issue Brief. 2002. PMID: 12083159 Free article.
Interest groups' influence over drug pricing policy reform in South Korea.
Chung WJ, Kim HJ. Chung WJ, et al. Yonsei Med J. 2005 Jun 30;46(3):321-30. doi: 10.3349/ymj.2005.46.3.321. Yonsei Med J. 2005. PMID: 15988802 Free PMC article. Review.
Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.
Andersson K, Petzold MG, Sonesson C, Lönnroth K, Carlsten A. Andersson K, et al. Health Policy. 2006 Dec;79(2-3):231-43. doi: 10.1016/j.healthpol.2006.01.007. Epub 2006 Feb 13. Health Policy. 2006. PMID: 16473436
Avoiding fundamental reform: current cost containment strategies in Canada.
Manga P. Manga P. J Health Hum Serv Adm. 1998 Spring;20(4):468-501. J Health Hum Serv Adm. 1998. PMID: 10338722
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Godman B, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83. doi: 10.1586/14737167.9.1.65. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19371180 Review.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page